Form D · Other Health Care

Elephas Biosciences Corp

Madison, WI · CIK 0001887402

Offering snapshot reported Jan 9, 2024 · SEC filing

Reported sold
$51.2M
Offering amount: $55M
Investors reported
10
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Nov 30, 2023
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 9, 2024Initial$51,218,994No comparison10SEC filing
Sep 14, 2022Initial$41,500,023No comparison7SEC filing
Oct 29, 2021Initial$1,000,000No comparison17SEC filing
Oct 14, 2021Initial$20,000,000No comparison5SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-501948

Source: Form D, filed Jan 9, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michelle B. Arora Director
Maneesh K. Arora Director, Executive
Paul Berns Director
Terrence Brady Executive
Steven Galson Director
Andrea Jackson Director
Jonathan Oliner Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
One Erdman Place Suite 100
Madison, WI, 53717